Clinical research of the value of high-risk CTV setting on intensity-modulated radiotherapy for stage IIB-IVA cervical cancer

被引：0
|
作者：
Yuqi Jiang
Jing Wang
Peng Jiang
Xiang Wang
Lei Zhang
Yongchun Zhang
机构：
[1] The Affiliated Hospital of Qingdao University,Department of Radiation Oncology
来源：
BMC Cancer | / 23卷
关键词：
Uterine cervical neoplasms; Neoplasm recurrence; Intensity modulated radiotherapy; Adverse effects; Simultaneous integrated boost intensity-modulated radiotherapy; High-risk CTV;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Clinical research of the value of high-risk CTV setting on intensity-modulated radiotherapy for stage IIB-IVA cervical cancer
    Jiang, Yuqi
    Wang, Jing
    Jiang, Peng
    Wang, Xiang
    Zhang, Lei
    Zhang, Yongchun
    BMC CANCER, 2023, 23 (01)
  • [2] Predictors of distant relapse in patients with FIGO stage IIB-IVA cervical cancer treated with definitive radiotherapy
    Okazawa-Sakai, Mika
    Mabuchi, Seiji
    Isohashi, Fumiaki
    Kawashima, Atsushi
    Yokoi, Eriko
    Ogawa, Kazuhiko
    Kimura, Tadashi
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2017, 43 (11) : 1743 - 1750
  • [3] Adjuvant concurrent chemoradiotherapy with intensity-modulated pelvic radiotherapy after surgery for high-risk, early stage cervical cancer patients
    Chen, Miao-Fen
    Tseng, Chih-Jen
    Tseng, Ching-Cheng
    Yu, Chun-Yen
    Wu, Chun-Te
    Chen, Wen-Cheng
    CANCER JOURNAL, 2008, 14 (03): : 200 - 206
  • [4] Value of pretreatment automated hemogram as a 5-year survival predictor in uterine cervical cancer clinical stage IIB-IVA
    Isabel Luna-Abanto, Luciana
    Fermin Yan-Quiroz, Edgar
    REVISTA DEL CUERPO MEDICO DEL HOSPITAL NACIONAL ALMANZOR AGUINAGA ASENJO, 2021, 14 (01): : 40 - 47
  • [5] Postoperative pelvic intensity-modulated radiotherapy and concurrent chemotherapy in intermediate- and high-risk cervical cancer
    Folkert, Michael R.
    Shih, Karin K.
    Abu-Rustum, Nadeem R.
    Jewell, Elizabeth
    Kollmeier, Marisa A.
    Makker, Vicky
    Barakat, Richard R.
    Alektiar, Kaled M.
    GYNECOLOGIC ONCOLOGY, 2013, 128 (02) : 288 - 293
  • [6] Clinical Results after High-Dose Intensity-Modulated Radiotherapy for High-Risk Prostate Cancer
    Fonteyne, Valerie
    Lumen, Nicolaas
    Villeirs, Geert
    Ost, Piet
    De Meerleer, Gert
    ADVANCES IN UROLOGY, 2012, 2012
  • [7] Intensity-modulated radiotherapy (IMRT)/Tomotherapy following neoadjuvant chemotherapy in stage IIB-IVA/B undifferentiated nasopharyngeal carcinomas (UCNT): A mono-institutional experience
    Franchin, Giovanni
    Vaccher, Emanuela
    Talamini, Renato
    Politi, Doriano
    Gobitti, Carlo
    Minatel, Emilio
    LLeshi, Arben
    Sartor, Giovanna
    Mascarin, Maurizio
    Abu Rumeileh, Imad
    Trovo, Mauro Gaetano
    Barzan, Luigi
    ORAL ONCOLOGY, 2011, 47 (09) : 905 - 909
  • [8] The Impact of Histological Subtype on Survival Outcome of Patients with Stage IIB-IVA Cervical Cancer Who Received Definitive Radiotherapy
    Miyahara, Shuko
    Tsuji, Keita
    Shimada, Muneaki
    Shibuya, Yusuke
    Shigeta, Shogo
    Nagai, Tomoyuki
    Umezawa, Rei
    Tokunaga, Hideki
    Jingu, Keiichi
    Yaegashi, Nobuo
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2021, 255 (04): : 303 - 313
  • [9] Clinical outcomes and late toxicity of hypofractionated intensity-modulated radiotherapy for high-risk prostate cancer.
    Wang, Michael
    Pearcey, Robert
    Pervez, Nadeem
    Yee, Don
    Mihai, Alina
    Patel, Samir
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [10] Cervical cancer stage IIB-IVA radiation therapy clinical responses based on spectral pulsed wave Doppler
    Muhammad, Syamel Syamel
    Suardi, Dodi Dodi
    Tobing, Maringan Maringan Diaptri Lumban
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 : 68 - 68
12345